Crystal Crop built portfolio through 13 strategic acquisitions

As of September 30, 2025, Crystal Crop Protection Limited described 13 strategic acquisitions as central to building its agrochemical and seed portfolio; acquired Proclaim, Tilt and Blue Copper generated Rs 182.66 crore in Fiscal 2025, compared with Rs 138.39 crore in their first post-acquisition fiscal year. The transactions added brands, germplasm, research assets and manufacturing capability.

How did Crystal Crop build its portfolio through acquisitions?

Crystal Crop built its portfolio through 13 strategic acquisitions spanning crop protection, seeds and manufacturing assets from 2011 to 2024. The company says it evaluates targets for their fit with its value chain, geographic reach, scientific capabilities, business verticals and product categories, alongside the presence of brands with established product-market fit.

In crop protection, the disclosed transactions included Luphos from Cheminova India Limited in 2012, Bavistin from BASF SE in 2016, and Proclaim, Tilt and Blue Copper from Syngenta entities in 2018. Crystal Crop also acquired Furadan 3G, Furadan Ultra, Splendour, Affinity Force and Metcil from FMC India Private Limited and Cheminova India Limited; Dursban, Predator and Nurelle D from Dow AgroSciences LLC; Gramoxone from Syngenta entities in 2023; and the Sunrice brand, Ethoxysulfuron-mixture patent and related know-how from Bayer entities in 2024.

The seed acquisitions expanded crop coverage and breeding resources. Crystal Crop acquired 90% of Rohini Seeds Private Limited in Fiscal 2011 and the remaining 10% in Fiscal 2014, which marked its entry into seeds. It subsequently acquired Syngenta India’s grain sorghum, fodder sorghum and pearl millet seed business in 2018, Bayer’s cotton, pearl millet and mustard portfolio in 2021, Kohinoor Seeds’ Sadanand cotton-seed business in 2023, and 100% of I&B Seeds Private Limited in 2024.

Which brands, seed assets and manufacturing capabilities came from acquisitions?

Crystal Crop acquired brands across herbicides, fungicides and insecticides, while the seed deals added field crops, vegetables, flowers, germplasm and breeding assets. As of September 30, 2025, Crystal Crop reported 60 herbicide brands, 57 insecticide brands, 34 fungicide brands and 23 bio-stimulant and plant-growth-regulator brands, together with more than 303 hybrid seed varieties.

The 2018 Syngenta acquisition of Proclaim, Tilt and Blue Copper was intended to support geographic expansion in Maharashtra and Karnataka and increase Crystal Crop’s insecticide market share, specifically for Emamectin. The products are used across multiple crops and geographies. Bayer’s 2024 transaction gave Crystal Crop the Sunrice brand in India, Thailand, Bangladesh and Vietnam, along with technology know-how and a patent for an Ethoxysulfuron mixture.

Seed acquisitions have widened the business beyond field crops. I&B Seeds added vegetable and marigold seeds after its October 2024 acquisition, and its Fiscal 2025 revenue contribution reflected only five months. Vegetable crops and flowers generated Rs 39.62 crore in Fiscal 2025, while seed revenue rose to Rs 469.88 crore, or 17.45% of revenue from operations, from Rs 301.33 crore, or 12.66%, in Fiscal 2023.

Crystal Crop also acquired immovable property and manufacturing assets from Cytec India in 2018 to expand technical-grade active ingredient production in India. Technicals are active agrochemical ingredients used to manufacture formulations. As of September 30, 2025, Crystal Crop’s two technical manufacturing units had combined installed capacity of 3,456 metric tonnes.

What revenue has Crystal Crop generated from acquired businesses?

Crystal Crop disclosed that six acquired brand and seed portfolios generated higher revenue in Fiscal 2025 than in their respective first post-acquisition fiscal years. The comparison does not cover all 13 acquisitions, but it shows the revenue progression for selected assets integrated into Crystal Crop’s portfolio.

The Bayer seed portfolio had the largest Fiscal 2025 revenue in the disclosed group at Rs 209.71 crore, compared with Rs 200.05 crore in its first post-acquisition fiscal year. The Syngenta fodder, grain sorghum and pearl millet seed business showed the largest proportional increase in the comparison, rising from Rs 20.52 crore to Rs 67.28 crore.

The disclosed revenue progress depends on Crystal Crop maintaining registrations, seed breeding, product supply and distribution for acquired portfolios. For example, the company held 583 domestic formulation registrations and 152 domestic Technicals registrations as of September 30, 2025, which are relevant to sustaining the sale of crop-protection products.

How does Crystal Crop integrate acquired brands and businesses?

Crystal Crop integrates acquisitions through its distribution network, distinct sales teams, research operations and manufacturing base. As of September 30, 2025, its network covered 23 states and four union territories and included 13,285 independent distributors, comprising 6,982 for Crystal brands, 3,712 for Saffire brands, 3,023 for field crops and 846 for vegetables and flowers.

The distributor totals overlap because 1,278 distributors were common to crop-protection brands and the seed business as of September 30, 2025. Crystal Crop operated separate, non-overlapping channels for the Crystal and Saffire crop-protection brands, while field crops and vegetables and flowers also had dedicated teams. The company had 460 sales and marketing executives for Crystal, 200 for Saffire, 149 for field crops and 212 for vegetable and flower seeds.

Acquired seed assets sit within a research platform that held 16,176 field-crop germplasm entries, 15,437 vegetable germplasm entries and 2,043 flower germplasm entries as of September 30, 2025. Germplasm is genetic plant material used for breeding. Crystal Crop also held 40 Plant Variety Protection registrations in cotton, pearl millet, sorghum and mustard, while I&B Seeds was described as having a 25% to 30% share of marigold flower seed sales during the preceding three years.

Why do acquisitions matter to Crystal Crop’s revenue mix?

Acquisitions matter because seeds became a larger part of Crystal Crop’s revenue mix between Fiscal 2023 and Fiscal 2025. Crop protection products and natural crop solutions remained the larger business at Rs 2,201.01 crore, or 81.74% of revenue from operations, in Fiscal 2025, but seed revenue increased by Rs 115.45 crore over the two-year period to Rs 469.88 crore.

Domestic branded seed sales rose to Rs 426.40 crore in Fiscal 2025 from Rs 277.23 crore in Fiscal 2023. Their share of domestic branded sales increased to 23.87% from 19.37% over the same period. This mix change reflects the acquired field-crop portfolios and the October 2024 addition of I&B Seeds, which brought vegetable and flower seed operations into Crystal Crop’s business.

The acquired products also operate within a larger domestic branded sales base. Domestic branded crop-protection sales were Rs 1,359.91 crore in Fiscal 2025, compared with Rs 426.40 crore for domestic branded seeds. Maintaining acquired brands therefore depends not only on seed expansion but also on crop-protection registrations, manufacturing availability and the company’s 13,285-distributor network as of September 30, 2025.

Conclusion

Crystal Crop’s disclosures show that acquisitions have been a central mechanism for portfolio construction, rather than a minor addition to internal development. The 13 transactions brought recognised agrochemical brands from Syngenta, BASF, Dow, FMC and Bayer, alongside seed businesses, breeding assets, germplasm and a technicals manufacturing facility. Revenue increased by Fiscal 2025 for each of the six acquired portfolios for which Crystal Crop provided comparable post-acquisition figures.

The next item to watch is the proposed Gujarat plant on 125,714.60 square metres of Gujarat Industrial Development Corporation land transferred provisionally on November 11, 2025. Crystal Crop says the proposed automated facility is intended to expand manufacturing capability and reduce reliance on third parties and imports, but the supplied disclosure does not state its capacity, commissioning date or commercial contribution.